MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy

ConclusionAchieving rCR corresponds well with pCR in HER2-positive breast cancer, particularly in the HR-negative subgroup. RCR is also associated with improved long-term outcome.

Source: Breast Cancer Research and Treatment - June 13, 2017 Category: Cancer & Oncology Source Type: research